LEADER 01071nam0-2200277 --450 
001 9910223059903321
005 20171129144035.0
010   $a354042377X
100   $a20171107d2001----kmuy0itay5050    ba
101 0 $aeng
102   $aDE
105   $a        001yy
200 1 $aMultiple criteria decision making in the new millennium$eproceedings of the fifteenth International conference on multiple criteria decision making (MCDM) Ankara, Turkey, July 10-14, 2000$fMurat Koksalan, Stanley Zionts (Eds.)
210   $aBerlin [etc.]$cSpringer$d[2001]
215   $aXII, 478 p.$d24 cm.
225 1 $aLecture notes in economics and mathematical systems$v507
702  1$aZionts,$bStanley
702  1$aKoksalan,$bMurat
710 12$aInternational conference on multiple criteria decision making (MCDM)$d<15.$f; 2000$e; Ankara>$4070$0747790
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910223059903321
952   $aXXXVI-A-9$fMAS
959   $aMAS
996   $aMultiple criteria decision making in the new millennium$91494426
997   $aUNINA

LEADER 03187nam  2200553 a 450 
001 9910828732303321
005 20240410171847.0
010   $a1-61668-450-X
035   $a(CKB)2550000001042609
035   $a(EBL)3020440
035   $a(SSID)ssj0000883492
035   $a(PQKBManifestationID)12403608
035   $a(PQKBTitleCode)TC0000883492
035   $a(PQKBWorkID)10923522
035   $a(PQKB)11578367
035   $a(MiAaPQ)EBC3020440
035   $a(Au-PeEL)EBL3020440
035   $a(CaPaEBR)ebr10676730
035   $a(OCoLC)923663801
035   $a(EXLCZ)992550000001042609
100   $a20101001d2010      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aMRSA (methicillin resistant Staphylococcus Aureus) infections and treatment$b[electronic resource] /$fManal M. Baddour
205   $a1st ed.
210   $aNew York $cNova Science Publishers$dc2010
215   $a1 online resource (140 p.)
225 1 $aPublic health in the 21st century series
300   $aDescription based upon print version of record.
311   $a1-61668-038-5 
320   $aIncludes bibliographical references (p. [83]-118) and index.
327   $aIntro -- MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS) INFECTIONS AND TREATMENT -- MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS) INFECTIONS AND TREATMENT -- CONTENTS -- PREFACE -- Chapter 1    INTRODUCTION AND TAXONOMY -- Chapter 2    THE CASE FOR MRSA -- Chapter 3    PREVALENCE AND EPIDEMIOLOGY -- Chapter 4    HOSPITAL ACQUIRED AND  COMMUNITY ACQUIRED -- Chapter 5    DIFFERING SPECTRUMS OF DISEASE -- Chapter 6    PANTON-VALENTINE LEUKOCIDIN -- Chapter 7    MECHANISM OF ?-LACTAM  RESISTANCE IN MRSA -- Chapter 8    MRSA COLONIZATION -- Chapter 9    CLINICAL RELEVANCE OF CA-MRSA -- Chapter 10    GISA VISA VRSA -- Chapter 11    LABORATORY DIAGNOSIS AND  TYPING OF MRSA -- PULSED-FIELD GEL ELECTROPHORESIS (PFGE) -- MULTILOCUS SEQUENCE TYPING (MLST) -- TYPING OF THE SPA LOCUS -- SCCMEC TYPING -- REPETITIVE SEQUENCE-BASED PCR (REP-PCR) -- RANDOMLY AMPLIFIED POLYMORPHIC  DNA (RAPD)-PCR -- Chapter 12    RISK FACTORS FOR HA-MRSA -- Chapter 13    RISK FACTORS FOR CA-MRSA -- Chapter 14    PREVENTION -- Chapter 15    TREATMENT OF METHICILLIN  RESISTANT STAPHYLOCOCCUS AUREUS -- ANTIBIOTIC DRUG DEVELOPMENT -- TREATMENT OF MRSA INFECTIONS -- Chapter 16    TREATMENT OF CA-MRSA -- Chapter 17    TREATMENT OF VISA AND VRSA -- Chapter 18    VANCOMYCIN TREATMENT FAILURES -- Chapter 19    TREATMENT OPTIONS AND  NEW DIRECTIONS -- Chapter 20    THE MICROBIOLOGY LABORATORY -- REFERENCES -- INDEX -- Blank Page.
410  0$aPublic health in the 21st century series.
606   $aStaphylococcus aureus infections
606   $aMethicillin resistance
615  0$aStaphylococcus aureus infections.
615  0$aMethicillin resistance.
676   $a579.3/53
700   $aBaddour$b Manal M$01718565
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910828732303321
996   $aMRSA (methicillin resistant Staphylococcus Aureus) infections and treatment$94115630
997   $aUNINA